Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950170-25-040217
Filing Date
2025-03-17
Accepted
2025-03-17 16:01:37
Documents
100
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 10-K mgx-20241231.htm   iXBRL 10-K 4333671
2 EX-10.14 mgx-ex10_14.htm EX-10.14 37710
3 EX-19.1 mgx-ex19_1.htm EX-19.1 220682
4 EX-23.1 mgx-ex23_1.htm EX-23.1 2467
5 EX-31.1 mgx-ex31_1.htm EX-31.1 20385
6 EX-31.2 mgx-ex31_2.htm EX-31.2 20903
7 EX-32.1 mgx-ex32_1.htm EX-32.1 21163
8 GRAPHIC img243784718_0.jpg GRAPHIC 473648
9 GRAPHIC img243784718_1.jpg GRAPHIC 435627
10 GRAPHIC img243784718_2.jpg GRAPHIC 255075
11 GRAPHIC img243784718_3.jpg GRAPHIC 509776
12 GRAPHIC img243784718_4.jpg GRAPHIC 87668
13 GRAPHIC img243784718_5.jpg GRAPHIC 125527
  Complete submission text file 0000950170-25-040217.txt   21052218

Data Files

Seq Description Document Type Size
14 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT mgx-20241231.xsd EX-101.SCH 1913526
103 EXTRACTED XBRL INSTANCE DOCUMENT mgx-20241231_htm.xml XML 2972480
Mailing Address 5959 HORTON STREET 7TH FLOOR EMERYVILLE CA 94608
Business Address 5959 HORTON STREET 7TH FLOOR EMERYVILLE CA 94608 (510) 871-4880
Metagenomi, Inc. (Filer) CIK: 0001785279 (see all company filings)

EIN.: 813909017 | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-41949 | Film No.: 25744299
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)